Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Recommendation of “Buy” from Brokerages
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have been assigned a consensus rating of “Buy” from the nine analysts that are currently covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1-year […]
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have been assigned a consensus rating of “Buy” from the nine analysts that are currently covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1-year […]
